CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.

@article{Duxbury2005CEACAM6IA,
  title={CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.},
  author={Mark S. Duxbury and Evan Matros and Thomas P. Clancy and Gerald Bailey and Michael Doff and M. J. Zinner and Stanley W Ashley and Anirban Maitra and Mark S. Redston and Edward E. Whang},
  journal={Annals of surgery},
  year={2005},
  volume={241 3},
  pages={491-6}
}
OBJECTIVE The purpose of this study was to test the hypothesis that CEACAM6 expression is an indicator of adverse pathologic features and clinical outcome in pancreatic adenocarcinoma. SUMMARY BACKGROUND DATA Previously, we have demonstrated carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) to be an oncoprotein that plays an important role in the biology of pancreatic adenocarcinoma. Suppression of CEACAM6 expression reduces tumorigenesis and metastasis in vivo. METHODS A… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…